Catheter Ablation for Atrial Fibrillation After Percutaneous Mitral Valve Repair

Not Applicable

• Conditions: Atrial Fibrillation; Heart Failure, Mitral Regurgitation, Percutaneous Mitral Valve Repair, Atrial Fibrillation

• Registration Number: JPRN-jRCTs042200051
• Lead Sponsor: Kinugawa Koichiro

Brief Summary

not applicable

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2020-10-19
• Study Completion: 2023-03-15
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 1

Inclusion Criteria

1)Patients undergoing percutaneous mitral valve repair (PMVR) for mitral regurgitation
2)Patients with paroxysmal or persistent atrial fibrillation. Diagnosis of atrial fibrillation is performed with a 12-lead electrocardiogram, a Holter electrocardiogram, an implantable device (ICD / CRT-D / loop recorder), or a portable electrocardiograph. Case registration is limited to cases where atrial fibrillation has been recorded within one year retroactively from study registration.
3)Age at the time of PMVR treatment is 20 years old or older and less than 90 years old

Exclusion Criteria

1)Patients undergoing percutaneous mitral valve repair (PMVR) for mitral regurgitation
2)Patients with paroxysmal atrial fibrillation (2 or more events lasting 30 seconds or more). Even if atrial fibrillation persists for 7 days or more, it is registered as paroxysmal atrial fibrillation when it becomes sinus rhythm by drug or cardioversion and then becomes paroxysmal atrial fibrillation. Diagnosis of atrial fibrillation is performed with a 12-lead electrocardiogram, a Holter electrocardiogram, an implantable device (ICD / CRT-D / loop recorder), or a portable electrocardiograph. Case registration is limited to cases where atrial fibrillation has been recorded within one year retroactively from study registration.
3)Age at the time of PMVR treatment is 20 years old or older and less than 90 years old

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
BNP, NT-proBNP

Secondary Outcome Measures

Name	Time	Method
All-cause death, Heart failure hospitalization, stroke, major bleeding